NEUROPATHY;PERIPHERAL
Clinical trials for NEUROPATHY;PERIPHERAL explained in plain language.
Never miss a new study
Get alerted when new NEUROPATHY;PERIPHERAL trials appear
Sign up with your email to follow new studies for NEUROPATHY;PERIPHERAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets nerve pain in rare blood cancers
Disease control OngoingThis study tests whether combining acalabrutinib with rituximab is safe and effective for people with nerve damage (neuropathy) linked to two blood conditions: IgM MGUS or Waldenstrom macroglobulinemia. The main goal is to see if the treatment lowers a key protein (IgM) in the bl…
Matched conditions: NEUROPATHY;PERIPHERAL
Phase: PHASE2 • Sponsor: Shayna Sarosiek, MD • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New hope for chemo pain: nerve zap study launches
Symptom relief OngoingThis study tests a treatment called neuromodulation to see if it can reduce nerve pain caused by chemotherapy. About 24 adults with nerve pain in their legs from certain chemo drugs will take part. Researchers will check for side effects and measure changes in pain and nerve func…
Matched conditions: NEUROPATHY;PERIPHERAL
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Soundwave therapy shows promise for chemo nerve damage
Symptom relief OngoingThis study tests a device called SensoniQ® Treatment Station that uses low frequency soundwaves to prevent or reduce nerve pain caused by chemotherapy in people with gynecologic cancer. The trial includes 80 participants, some starting chemo and others with lasting nerve pain. Re…
Matched conditions: NEUROPATHY;PERIPHERAL
Phase: NA • Sponsor: Augusta University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC